Notably, levels of cathepsin B have been shown to be increased in the tissues or serum of cancer patients diagnosed with CCA, thyroid cancer, or colorectal cancer (McKerrow et al., 2000; Srisomsap et al., 2002; Monsouvanh et al., 2014). This evidence concerns the gene CTSB and cholangiocarcinoma.